NADOLOL
- Product NDC
- 69025-002
- 11-digit product format
- 690250002
- Labeler code
- 69025
- Product ID
- 69025-002_b968eb86-12b8-6681-e053-2a95a90a62fa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NADOLOL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aizant Drug Research Solutions Pvt Ltd
- Application
- ANDA212856
- Marketing category
- ANDA
- Marketing start
- 2020-06-30
- Marketing end
- 0000-00-00
- Substance
- NADOLOL
- Active strength
- 80 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69025-002-00 | 69025000200 | 100 TABLET in 1 BOTTLE, PLASTIC (69025-002-00) | 100 tablet | 2020-06-30 | 0000-00-00 | No | No | Current |